Introducing Color To More Than 100 Countries – Color

October 17, 2017

Today, we are thrilled to announce that Color is now available to individuals and healthcare providers in more than 100 countries. The Color Test is a physician-ordered genetic test for breast and ovarian cancer risk. Since Color launched in 2015, we have received emails and... Read More

Color Genomics Joins Precision Medicine Initiative to Help Make Genetic Testing More Accessible and Advance Cancer Research

October 17, 2017

In an unusually exciting Thursday, members of the Color team participated in the Precision Medicine Initiative Summit at the White House to mark the one-year anniversary of President Obama’s Precision Medicine Initiative (PMI). Color was invited to join PMI to help... Read More

Introducing Color’s Provider Platform: Bringing Efficiency and Simplicity to Genetic Testing

October 17, 2017

Color’s mission is to democratize access to genetic testing in a responsible way. A major part of responsible access is ensuring that healthcare providers can easily order Color for their patients, and then understand and engage with their patients’ Color Test... Read More

BRCA1, BRCA2 and Other Cancer Risk Genes: Five Facts About Why They Also Matter for Men

October 17, 2017

Throughout the month of October, genetic counselors at Color held educational sessions about genetic testing for hereditary breast and ovarian cancer risk. Men in the audience commonly asked, “How is this genetic test relevant to me?” Many men thought that the... Read More

Color Genomics Partners with University of California Health System in Landmark Athena WISDOM Study

October 17, 2017

We are excited to announce that Color has been selected as the genomics partner for the Athena WISDOM Study, a $14.1 million-funded University of California (UC) Health system-wide program in collaboration with Salesforce and Blue Shield of California. The WISDOM Study was... Read More

Engineering a Modern Genetics Company – Color

October 17, 2017

Color’s mission is to democratize access to genetic testing. In order to achieve this, running a cost efficient and scalable service is crucial. From day one, Color was built as a software-driven company, with engineers working side-by-side with all functional teams to... Read More

The Color Benefits Program: Leading Organizations Pledge to Cover 50% or More of the Cost of Breast and Ovarian Cancer Risk Testing for Employees

October 17, 2017

Not a week goes by when we don’t hear of a story — either in our personal lives or in public media — about someone discovering that they have a high-risk genetic mutation only after they have been diagnosed with breast or ovarian cancer. Each one of these cases is a missed... Read More

Color Genomics Offers $199 Price For October’s Breast Cancer Awareness Month

October 17, 2017

October starts this Thursday and it’s a special month to Color Genomics. This marks our first Breast Cancer Awareness Month since our launch in April. Breast Cancer Awareness Month has become an annual international health campaign organized by major breast cancer... Read More

Meeting the Breast and Ovarian Cancer Community at the 2015 FORCE Annual Conference

October 17, 2017

Color’s mission is to democratize access to genetic testing, and to do so in a thoughtful and responsible way. Every test requires a physician order and includes genetic counseling. Our approach emphasizes high quality results and a simple, seamless experience for our clients.... Read More

Cancer Touches Everyone – Color

October 17, 2017

Everyone’s life has been touched by cancer. There are millions of survivors among us. Our family members and friends have suffered from cancer or passed away from the disease. The intrusion of this disease into our lives leaves a trail of incomprehension. While the... Read More

Color’s BRCA Test: affordable, accessible, ready to save lives

October 5, 2017

For hundreds of years doctors have known that breast cancer can run in families, but not why or how. Then in 1990, Dr. Mary-Claire King and her team published a paper proving the existence of a gene whose mutations cause increased risk for the disease. We now know that this... Read More

Celebrating Those Who Inspire Us – Color

October 2, 2017

October marks the beginning of Breast Cancer Awareness Month. Breast cancer, the most common cancer among women in the US, has impacted the lives of far too many loved ones. This month communities come together to raise awareness of breast cancer risks and the value of... Read More

Color’s September Newsletter, Spectrum – Color

September 29, 2017

Color’s monthly newsletter, Spectrum, helps you stay up to date on living a healthy life with the latest in health and wellness, genetics, and cancer and heart health. If you found this information interesting, sign up for our monthly Health Notes here. Health &... Read More

A great doctor and his grateful patient – Color

September 29, 2017

Dr. Adashek & his patient Chris Scott Walking into Dr. Steven J. Adashek’s office, you can’t help but notice how welcoming it feels. The brightly colored walls are lined with beautiful artwork created by patients who‘ve been coming here for many years.... Read More

The Dream Team you haven’t heard about

September 26, 2017

At Color, our belief that genetic testing should be, and can be, affordable and accessible applies to our approach to research partnerships, along with everything else. That’s why we’re proud to announce our collaboration with a Stand Up to Cancer Dream Team for the MAGENTA... Read More

Full Transcript: Greg Simon, Director of the Biden Cancer Initiative, on Sequenced

September 25, 2017

On this episode of Sequenced, we talk to Greg Simon, Director of the Biden Cancer Initiative and previously the Executive Director of the White House Cancer Moonshot Task Force. Greg discusses the impetus behind Cancer Moonshot and how government, physicians, researchers,... Read More

Full Transcript: Lindsay Avner, Founder and CEO of Bright Pink, on Sequenced

September 25, 2017

On this episode of Sequenced, we talk to Lindsay Avner, Founder and CEO of Bright Pink. Lindsay underwent genetic testing at age 22. The test revealed she carried a mutation on the BRCA1 gene. At 23, she became the youngest woman in the U.S. to undergo a risk-reducing double... Read More

Full Transcript: Chrissy Farr Interviews Vinod Khosla on Sequenced

September 25, 2017

On this episode of Sequenced, Vinod Khosla, renowned Silicon Valley entrepreneur and investor, sits down with CNBC’s Chrissy Farr to discuss how technology will reinvent healthcare as we know it. Ready to dive deeper into the topic? You can find Vinod’s full... Read More

Full Transcript: Hemant Taneja, Managing Director at General Catalyst, on Sequenced

September 25, 2017

On this episode of Sequenced, Hemant Taneja, Managing Director at General Catalyst, discusses the changing nature of startups, how they are being built, and how it applies to the healthcare sector. We’ve posted complete transcript of the podcast below. You can subscribe... Read More

Full Transcript: Aneesh Chopra, the United States’ first Chief Technology Officer, on Sequenced

September 25, 2017

On this episode of Sequenced, Aneesh Chopra, the United States’ first Chief Technology Officer under President Barack Obama, sat down with Color’s CEO and co-founder Othman Laraki to discuss the intersection between data and healthcare. We’ve posted complete... Read More